pLenti-PGK-KRAS4A(G12V) Citations (2)

Originally described in: TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers.
Singh A, Sweeney MF, Yu M, Burger A, Greninger P, Benes C, Haber DA, Settleman J Cell. 2012 Feb 17;148(4):639-50. PubMed Journal

---

Articles Citing pLenti-PGK-KRAS4A(G12V)

Articles
AMP kinase promotes glioblastoma bioenergetics and tumour growth. Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B. Nat Cell Biol. 2018 Jul;20(7):823-835. doi: 10.1038/s41556-018-0126-z. Epub 2018 Jun 18. PubMed
The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer. Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, Chan LS, Luk STY, Tong S, Xu J, Zhou Q, Liu D, Su H, Gou H, Cheung AH, To KF, Cai Z, Shay JW, Yu J. Nat Commun. 2022 Jul 8;13(1):3971. doi: 10.1038/s41467-022-31663-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.